Using biomarkers to predict CKD in diabetes

This survey is asking for feedback on proposed research to see if newly identified biomarkers can help predict chronic kidney disease in people with diabetes.

Between 30 and 40% of people with diabetes will develop chronic kidney disease (CKD), which can lead to kidney failure requiring dialysis or even a kidney transplant.  The proposed research will investigate recently identified microRNA molecules to see if they can be used to develop tests for early identification of CKD.

It is being carried out by a team of researchers based at Manchester Metropolitan University in collaboration with Salford Royal Hospital, part of the Northern Care Alliance NHS Foundation Trust.

This study has ended and is currently not accepting new applicants.

Share this study